AI-designedGENE THERAPY
An autonomous AI agent stack designing the next generation of delivery vectors for gene therapy — from exosomes shipping today to programmable LNPs built for any cell type.
One token to fund the platform.
Delivery is the last unsolved problem in genetic medicine.
We build the delivery vectors.
Engineered exosomes
Nature's targeted nanocarrier — isolated, loaded, and delivered. Intranasal formulation, low immunogenicity, tunable tropism.
AI-designed LNPs
Synthetic, programmable lipid nanoparticles designed by agents for any cell type. Proposed, simulated, gated, and re-prioritized autonomously.
The first vector, ready to deliver.
Our first deployable vector: engineered exosomes in an intranasal formulation. Nature's nanocarrier — isolated, loaded, and routed across the nasal mucosa. The proof the platform works, made real.
- Intranasal route
- Exosome carrier
- Low immunogenicity
- RNA / protein cargo
- Tunable tropism
Vector 01 is the first output of the Exo platform. The agents are already designing Vector 02 — programmable synthetic LNPs.
One agent stack.
Every vector, every cell.
Exo agents
An autonomous fleet designing programmable delivery vectors — reading, simulating, dispatching to the wet lab, filing IP. 24/7.
Vectors that ship
Gen 1: exosomes — nature's targeted nanocarrier, in the clinic now. Gen 2: AI-designed LNPs for any receptor, any tissue.
The token
$EXO funds the agent stack and shares the upside — onchain, community-owned.
Back the agent stack.
$EXO funds the agent fleet, the vectors they design, and the IP — community-owned, onchain. Drop your email; we'll ping you the moment the launch is live.